Hologic

Hologic, Inc. is a medical technology company primarily focused on women’s health; it sells medical devices for diagnostics, surgery, and medical imaging.[2]

Hologic
Public
Traded as
ISINUS4364401012 
IndustryMedical devices
Founded1985[1]
Headquarters
Marlborough 
,
United States of America 
Key people
Number of employees
6,478[1][2] (2019)
Websitewww.hologic.com

In late November 2013, activist investor Carl Icahn disclosed a 12.5% stake in the company. Subsequently, the company adopted a poison pill to prevent a hostile takeover. In negotiations with the Company's board of directors, two additional directors backed by Mr. Icahn were added to the board, each managing directors of Icahn holding companies.[3] Icahn considered his investment and intervention into Hologic to have been a success, with his nominees to the board of directors resigning on March 3, 2016[4] and exiting his position by May 16, 2016.[5]

In 2017, Hologic acquired Westford, Massachusetts-based aesthetic medicine company Cynosure for $1.65 billion.[6]

On November 20, 2019, Hologic announced the divestment of Cynosure to Clayton, Dubilier & Rice for $205 million;[7] this was completed on December 30, 2019.[8] Cynosure had ~825 employees at the time of the divestiture.[9][6]

In March 2020, Hologic received emergency use authorization from the FDA for a test for 2019-nCoV to help mitigate the COVID-19 pandemic.[10] In May 2020, Hologic received a second emergency use authorization from the FDA for 2019-nCov to increase potential throughput of testing. [11]

In June 2020, Hologic collaborated with Grifols, a global producer of plasma-driven medicines, to increase Spain's testing capacity for COVID-19.[12]

References
  1. "Hologic, Inc. (HOLX)". Yahoo! Finance. Retrieved January 11, 2020.
  2. "Hologic Inc. Profile". MarketWatch.com. Retrieved January 11, 2020.
  3. Grover, Natalie (December 9, 2013). "Hologic names new CEO, adds two Icahn nominees to board". Reuters.com. Archived from the original on October 1, 2018.
  4. Adams, Dan (March 4, 2016). "Carl Icahn cashes in on Hologic success". Boston Globe. Archived from the original on September 3, 2019. Retrieved January 6, 2020.
  5. Witkowski, Wallace (May 6, 2016). "Icahn exits Gannett, Hologic positions; adds to Xerox". MarketWatch.com. Archived from the original on July 5, 2017. Retrieved January 6, 2020.
  6. Stempniak, Marty (January 3, 2020). "Breast imaging company Hologic unloads aesthetics line at $1B-plus loss". RadiologyBusiness.com. Archived from the original on January 6, 2020. Retrieved January 5, 2020.
  7. "Hologic to Sell Cynosure Medical Aesthetics Business to Clayton, Dubilier & Rice". BusinessWire.com. November 20, 2019. Retrieved January 11, 2020.
  8. "Hologic Completes Divestiture of Cynosure Medical Aesthetics Business". Yahoo! Finance. Business Wire. December 30, 2019. Retrieved January 5, 2020.
  9. "Hologic (HOLX) Divests Cynosure to Focus on Women's Health". Zacks.com. January 2, 2020. Archived from the original on January 6, 2020. Retrieved January 5, 2020.
  10. "FDA Approves Abbott Laboratories Coronavirus Test, Company To Ship 150,000 Kits". IBTimes.com. 19 March 2020. Archived from the original on 20 March 2020.
  11. "Hologic's latest COVID-19 test gets FDA approval for emergency use". reuters.com. 29 May 2020. Archived from the original on 29 May 2020.
  12. MarketScreener. "Hologic : Grifols and Hologic embark on a unique collaboration for COVID-19 testing in Spain | MarketScreener". www.marketscreener.com. Retrieved 2020-07-07.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.